Skip to main content

Advertisement

ADVERTISEMENT

News

Evolution
News
12/08/2023
HMP Global's 2023 Evolution of Psychotherapy conference is set to provide an enriching 5-day educational experience for psychotherapy and mental health care professionals.
HMP Global's 2023 Evolution of Psychotherapy conference is set to provide an enriching 5-day educational experience for psychotherapy and mental health care professionals.
HMP Global's 2023 Evolution of...
12/08/2023
Psychiatry & Behavioral Health
Neuroactive Nasal Spray Promising Treatment for SAD
News
12/07/2023
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a...
12/07/2023
Psych Congress Network
brain and pills
News
12/07/2023
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine...
12/07/2023
Psych Congress Network

Advertisement

a woman struggles to sleep
News
12/05/2023
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to...
12/05/2023
Neurology
Adding Drug-Drug Interactions, Lifestyle Factors Boosts Pharmacogenomics Guidance
News
12/04/2023
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug...
12/04/2023
Psych Congress Network
Stock Doctor
News
12/01/2023
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at...
12/01/2023
Psych Congress Network

Advertisement

Link Established Between Adult ADHD and Elevated Dementia Risk
News
12/01/2023
Adult attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of dementia, according to cohort study results published in JAMA Network Open. 
Adult attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of dementia, according to cohort study results published in JAMA Network Open. 
Adult...
12/01/2023
Psych Congress Network
alzheimer sleep
News
11/30/2023
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a...
11/30/2023
Psych Congress Network
Solriamfetol Improves Cognitive Impairment Associated With OSA, EDS
News
11/28/2023
Solriamfetol improved objective and subjective measures of cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS), according to a poster presentation at...
Solriamfetol improved objective and subjective measures of cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS), according to a poster presentation at...
Solriamfetol improved objective...
11/28/2023
Psych Congress Network

Advertisement

BIIB080 Reduces Tau Biomarkers in Patients With Mild Alzheimer Disease
News
11/28/2023
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers...
11/28/2023
Psych Congress Network

Advertisement